The United States and Switzerland struck a landmark framework trade agreement on Friday, slashing tariffs on imported Swiss products from 39% to 15% while Swiss companies commit to invest $200 billion in the U.S. by the end of 2028. Washington announced the deal alongside Liechtenstein, with negotiations to finalize the trade deal set for completion by the first quarter of 2026, according to a White House statement.
U.S. Trade Representative Jamieson Greer called the agreement a breakthrough that tears down longstanding trade barriers and opens new markets for American goods. The massive Swiss investment aims to reduce deficit in pharmaceuticals and other key sectors, promising to generate thousands of jobs across the country. At least $67 billion of the total pledge arrives in 2026, targeting target sectors including medical devices, aerospace, and gold manufacturing. The arrangement marks a turning point in transatlantic commercial relations, addressing concerns that have lingered since trade tensions escalated between major economic partners.
Historic Tariff Reduction Levels Playing Field with EU
Swiss Economy Minister Guy Parmelin declared the deal puts Switzerland on equal footing with the European Union, bringing the tariff level down dramatically. The reduction affects roughly 40% of Switzerland’s exports to the U.S. market. “Of course, we would prefer this money to be invested in Switzerland,” Parmelin acknowledged, noting the Federal Council works in parallel to reduce costs for domestic businesses.
The lower tariff rate gets activated within “days, weeks,” once U.S. customs processing systems are adjusted, said Helene Budliger Artieda, director of Switzerland’s State Secretariat for Economic Affairs. She confirmed a large portion of investments in U.S. production flows from pharmaceuticals and life sciences sectors, though she declined to provide specifics. Pharmaceuticals remains the largest export sector from Switzerland to America. Swiss officials believe the rapid implementation timeline demonstrates both nations’ commitment to strengthening bilateral commerce and creating tangible benefits for workers and manufacturers on both sides of the Atlantic.
Pharmaceutical Giants Secure Critical Protection from Trump Tariffs
The deal guarantees a 15% tariff ceiling for Swiss drugmakers, including Roche and Novartis, shielding them from U.S. President Donald Trump’s forthcoming Section 232 national security duties for the sector, which could reach 100% for certain patented drugs. Parmelin emphasized the cap applies to future Section 232 duties, including semiconductors, maintaining the same footing as the EU.
“The risk of much higher sector-specific tariffs is therefore ruled out,” Parmelin added. A Swiss government statement confirmed the tariff agreement, which includes neighboring Liechtenstein, will reduce Swiss import duties on U.S. industrial products, fish, seafood, and agricultural products that Switzerland considers non-sensitive. Switzerland will grant the U.S. duty-free bilateral tariff quotas on 500 tons of beef, 1,000 tons of bison meat, and 1,500 tons of poultry meat, the government announced. These concessions reflect Switzerland’s willingness to open its domestic market while securing predictable access for its premium manufactured goods.
Swiss Industrial Sector Celebrates Competitive Breakthrough
Swiss industrial groups welcomed the deal, saying it establishes a level playing field with competitors from the European Union, which agreed to a 15% rate on EU exports. The industrial sector, which had been subject to punishing duties since August 1, finally gets relief. “For the first time, we have the same conditions in the U.S. market as our European competitors,” said Nicola Tettamanti, president of Swissmechanic, which represents small and medium-sized manufacturers.
“It’s a great relief on tariffs, but additional economic burdens and risks remain,” warned Hans Gersbach, director of the KOF Swiss Economic Institute at ETH Zurich. Switzerland’s machinery, precision instruments, watchmaking, and food sectors, which export to America, see the most relief, Gersbach explained. KOF forecasts Swiss economic growth of 0.9% in 2026, but this could exceed 1% with the reduced rate, he added. Manufacturing executives across Switzerland now face the challenge of ramping up production capacity to meet anticipated demand from American buyers who previously sought alternative suppliers.
Trade Surplus Data Reveals Front-Loading Strategy Impact
Switzerland maintained a $38.3 billion goods trade surplus with the U.S. in 2024, according to U.S. Census Bureau data. That figure rose to $55.7 billion in 2025 through July, reflecting primarily the front-loading of imports during first quarter, before Donald Trump imposed his “reciprocal tariffs” in early April.
Nadia Gharbi, an economist at Swiss bank Pictet, said the tariff reduction removed the main downside risks for the country’s economy and represents a clearly positive development for Swiss industries and the overall growth outlook. Under the previous tariff regime, Switzerland suffered significant loss of competitiveness—not only because of the strength of the Swiss franc, but also because neighboring European economies faced duties of only around 15%, she explained.
Export Data Shows Severe Damage from Earlier Tariff Shock
Swiss industry reported a 14% fall in exports to the U.S. during the three months through September, according to the technology industry association Swissmem. Machine tool makers saw shipments slump 43%, highlighting the severe damage inflicted before this breakthrough agreement. The recovery timeline remains uncertain, though industry leaders express cautious optimism about regaining lost ground in coming quarters.